We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
-5.44%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.06B
AUM Growth
-$215M
(-4.1%)
Cap. Flow
-$288M
Cap. Flow
% of AUM
-5.68%
Top 10 Holdings %
Top 10 Hldgs %
52.55%
Holding
152
New
45
Increased
20
Reduced
17
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$94.3M |
| 2 |
Pfizer
PFE
|
+$87.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$79.4M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$38.7M |
| 5 |
Insmed
INSM
|
+$35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WAY
Waystar Holding Corp
WAY
|
+$121M |
| 2 |
ACH
Accendra Health
ACH
|
+$64.2M |
| 3 |
Alignment Healthcare
ALHC
|
+$40.8M |
| 4 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$38.8M |
| 5 |
BCAX
Bicara Therapeutics
BCAX
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.22% |
| 2 | Real Estate | 0.01% |
| 3 | Technology | 0.01% |
| 4 | Consumer Discretionary | 0.01% |
| 5 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFLY.WS
101
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
| $66K | ﹤0.01% |
733,333
| – | – |
|
102
Cerus
CERS
$585M
| $62.1K | ﹤0.01% |
44,693
-5,612
| -11% | -$9.39K |
|
103
Aldeyra Therapeutics
ALDX
$95.3M
| $59.4K | ﹤0.01% |
+10,328
| New | +$61.1K |
|
104
Sunrun
RUN
$2.3B
| $59.3K | ﹤0.01% |
+10,124
| New | +$83.4K |
|
105
Rezolute
RZLT
$474M
| $55.7K | ﹤0.01% |
+19,223
| New | +$83.7K |
|
|
NUVB.WS
106
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $53.3K | ﹤0.01% |
166,666
| – | – |
|
107
MaxCyte
MXCT
$112M
| $52.2K | ﹤0.01% |
+19,121
| New | +$75.4K |
|
108
Acco Brands
ACCO
$401M
| $47.1K | ﹤0.01% |
11,242
-3,315
| -23% | -$16.3K |
|
109
Digital Turbine
APPS
$1.02B
| $46K | ﹤0.01% |
+16,942
| New | +$55K |
|
|
OLPX
110
DELISTED
Olaplex Holdings
OLPX
| $36.6K | ﹤0.01% |
+28,833
| New | +$42.7K |
|
111
Talkspace
TALK
$873M
| $34.4K | ﹤0.01% |
+13,446
| New | +$41.9K |
|
|
TOIIW
112
The Oncology Institute Warrant
TOIIW
$4.36M
| $33.9K | ﹤0.01% |
1,250,000
| – | – |
|
113
Community Health Systems
CYH
$393M
| $31.6K | ﹤0.01% |
+11,717
| New | +$36.5K |
|
114
Butterfly Network
BFLY
$1.88B
| $26.5K | ﹤0.01% |
+11,635
| New | +$41.6K |
|
115
C4 Therapeutics
CCCC
$393M
| $20K | ﹤0.01% |
+12,528
| New | +$37.4K |
|
116
Surrozen Inc Warrant
SRZNW
$75.6K
| $5K | ﹤0.01% |
166,666
| – | – |
|
117
BRC Inc
BRCC
$118M
| – | – |
-15,029
| Closed | -$47.6K |
|
118
Corvus Pharmaceuticals
CRVS
$1.12B
| – | – |
-1,000,000
| Closed | -$5.35M |
|
119
Emergent Biosolutions
EBS
$377M
| – | – |
-14,058
| Closed | -$134K |
|
120
Ecovyst
ECVT
$1.35B
| – | – |
-10,317
| Closed | -$78.8K |
|
121
Vaalco Energy
EGY
$540M
| – | – |
-20,897
| Closed | -$91.3K |
|
122
Fate Therapeutics
FATE
$270M
| – | – |
-3,555,871
| Closed | -$5.87M |
|
123
GoodRx Holdings
GDRX
$1.06B
| – | – |
-11,990
| Closed | -$55.8K |
|
124
General Mills
GIS
$20.1B
| – | – |
-3,455
| Closed | -$220K |
|
|
LKFT
125
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| – | – |
-1,411,000
| Closed | -$38.8M |
|
Similar funds
FT
GRQ
PCM
VA
QC
IC
NW
AAF
Deerfield Management's Q1 2025 Portfolio in Review
As of Q1 2025, Deerfield Management held 152 positions worth $5.06B, down 4.1% from $5.28B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Deerfield Management withdrew a net $288M in Q1 2025, closing 29 positions and reducing 17 holdings. Its most notable exit was Waystar Holding Corp, an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 88% a quarter earlier, followed by Real Estate and Technology.
Against the trend, Deerfield Management opened a new position in United Therapeutics worth $84.8M.
- Deerfield Management's largest Q1 2025 buy was United Therapeutics: 275,226 shares worth $84.8M.
- Deerfield Management added most to Neurocrine Biosciences in Q1 2025, an estimated $79.4M increase.
- Deerfield Management's biggest Q1 2025 reduction was Alignment Healthcare, cutting an estimated $40.8M.
- Deerfield Management fully exited Waystar Holding Corp in Q1 2025, selling an estimated $121M.
- Deerfield Management's ten largest holdings make up 53% of its $5.06B portfolio in Q1 2025.
- Deerfield Management opened 45 new positions and closed 29 in Q1 2025.
- Deerfield Management's portfolio value fell 4.1% quarter-over-quarter to $5.06B.
Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.